Pleural Effusion clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • LTI-01 in Patients With Infected, Non-draining Pleural Effusions

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18 years and up

    The LTI-01-2001 study is a double-blind, placebo-controlled, Phase 2 study to evaluate LTI-01 (single-chain urokinase plasminogen activator, scuPA) in patients with infected, non-draining pleural effusions.

    Sacramento, California and other locations

Last updated: